查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1552489

甲黴菌病全球市場、規模、佔有率、趨勢、行業分析報告：依類型、治療、地區 - 市場預測，2024-2032

Global Onychomycosis Market Size, Share, Trends, Industry Analysis Report: By Type, By Treatment (Topical, Oral and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) - Market Forecast, 2024 - 2032.
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球甲黴菌病市場規模預計將達到56.8946億美元。本研究報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

由於人們對真菌疾病的認識不斷提高以及公眾意識的增強，甲真菌病市場顯著成長。這使得人們能夠及早發現並更了解甲黴菌病等真菌感染的影響。

2023年 9月，美國疾病管制與預防中心 (CDC) 認可了真菌疾病意識週 (FDAW) 。每年，疾病預防控制中心及其合作夥伴都會參與倡議和外展活動，以提高公眾對真菌感染的認識。在2023年 FDAW 即將到來之際，各種事件凸顯了真菌疾病日益嚴峻的挑戰、複雜性和重大影響。

此外，雷射已獲得美國食品藥物管理局 (FDA) 的批准，技術的進步導致其用於治療甲黴菌病，有助於市場的擴大。

根據Indian Dermatology Online Journal報導，局部治療與點陣 CO2 雷射結合可以提高甲黴菌病治療的效果。有幾個因素會影響治療結果，包括甲板厚度、甲黴菌病的程度和類型、療程次數和同時治療。點陣 CO2 雷射治療透過在指甲上形成一個開口，在 42 天內將局部藥物輸送改善 3-4 倍。因此，使用點陣CO2雷射作為甲黴菌病局部治療的預處理是有益的。

此外，與外用抗真菌藥物相比，口服治療甲真菌病的成功率更高、治療時間更短，因此越來越受到患者的歡迎。這種真菌疾病的主要治療方法是口服terbinafine hydrochloride。許多仿製藥製造商推出口服藥物來解決日益增多的甲黴菌病病例。

例如，2021 年 6 月，Glenmark Pharmaceuticals 的治療等效和生物等效茶鹼緩釋片獲得美國FDA批准，有450毫克和300毫克兩種規格，用於治療甲黴菌病。

甲黴菌病市場報告亮點

遠端甲下甲黴菌病市場佔據主導地位。這是由於對治療甲黴菌病的更有效藥物的需求不斷成長，導致 FDA 批准的數量不斷增加。

在預測期內，外用藥物細分市場佔據主導地位，因為外用藥物的副作用較少。

在預測期內，由於目標疾病發生率的增加和政府政策的支持，北美地區主導了市場。

由於獲得醫療服務的機會有限、衛生習慣不佳以及城市化進程加快，亞太地區預計將出現最快的年複合成長率。

目錄

第1章 簡介

第2章 執行摘要

第3章 研究方法

第4章 全球甲黴菌病市場洞察

  • 市場快照
  • 甲真菌病市場動態
    • 推動因素和機會
      • 對局部治療的需求不斷成長推動市場成長
      • 先進科技的崛起推動市場成長
    • 抑制因素和挑戰
      • 存在替代療法
  • PESTEL 分析
  • 甲真菌病市場的應用趨勢
  • 價值鏈分析
  • 新冠肺炎 (COVID-19) 影響分析

第5章 全球甲黴菌病市場：依類型

  • 主要調查結果
  • 簡介
  • 遠端甲下甲黴菌病
  • 近端甲下甲黴菌病

第6章 全球甲黴菌病市場：依治療

  • 主要調查結果
  • 簡介
  • 局部
  • 口頭
  • 其他

第7章 全球甲黴菌病市場：依地區

  • 主要調查結果
  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 亞太地區其他地區
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東、非洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區

第8章 競爭態勢

  • 擴張與收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/揭露

第9章 公司簡介

  • Abbott
  • Bausch Health Companies Inc.
  • Cipla Inc.
  • Merck & Co., Inc.
  • Moberg Pharma AB
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Zydus Lifesciences
Product Code: PM5011

The global onychomycosis market size is expected to reach USD 5,689.46 million by 2032, according to a new study by Polaris Market Research. The report "Global Onychomycosis Market Size, Share, Trends, Industry Analysis Report: By Type, By Treatment (Topical, Oral and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) - Market Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The onychomycosis market is experiencing significant growth due to increased recognition of fungal diseases and improved public awareness. This has led to early detection and better understanding of the effects of fungal infections, such as onychomycosis.

In September 2023, the Centers for Disease Control and Prevention (CDC) recognized Fungal Disease Awareness Week (FDAW). Every year, the CDC and its partners participate in initiatives and outreach efforts to raise public awareness of fungal infections. Leading up to FDAW in 2023, various events emphasized the growing challenges, complexities, and significant impacts of fungal diseases.

Furthermore, lasers have received approval from the Food and Drug Administration (FDA), and technological advancements have led to the use of lasers in the treatment of onychomycosis, contributing to the expansion of the market.

As per the Indian Dermatology Online Journal, combining topical therapy with fractional CO2 laser can enhance the effectiveness of onychomycosis treatment. Several factors, such as nail plate thickness, extent and type of onychomycosis, number of sessions, and concurrent therapy, can influence treatment results. Fractional CO2 laser treatment involves creating openings in the nail, which improves the delivery of topical drugs by three to four times over 42 days. Therefore, using fractional CO2 laser as a pre-treatment alongside topical therapy for onychomycosis can be beneficial.

Furthermore, oral treatment for onychomycosis is becoming increasingly popular among patients due to its higher success rates and shorter treatment durations compared to topical antifungals. The main treatment for this fungal infection is oral terbinafine hydrochloride. Many generic manufacturers are introducing oral treatments to address the growing prevalence of onychomycosis.

For instance, in June 2021, Glenmark Pharmaceuticals was granted approval by the U.S. FDA for their therapeutically equivalent and bioequivalent theophylline extended-release tablets, available in 450 mg and 300 mg for the treatment of onychomycosis.

Onychomycosis Market Report Highlights

The distal subungual onychomycosis segment dominated the market. This is due to the rising number of approvals by the FDA in response to the increasing demand for more effective medications for onychomycosis treatment.

The topical segment dominated the market over the forecast period as topical treatments are associated with fewer side effects.

The North America region dominated the market over the forecast period owing to the increased occurrence of the target disease and supportive government policies.

The Asia-Pacific region is expected to grow at the fastest CAGR owing to the limited access to healthcare services, poor hygiene practices, and extensive urbanization.

The global key market players include Bausch Health Companies Inc., Moberg Pharma AB, Abbott, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Cipla Inc., Merck & Co., Inc., Novartis AG, Zydus Lifesciences and Sun Pharmaceutical Industries Ltd.

Polaris Market Research has segmented the onychomycosis market report based on type, treatment, and region:

Onychomycosis, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Distal Subungual Onychomycosis
  • Proximal Subungual Onychomycosis
  • White Superficial Onychomycosis
  • Others

Onychomycosis, Treatment Outlook (Revenue - USD Million, 2019 - 2032)

  • Topical
  • Oral
  • Others

Onychomycosis, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Vietnam
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Onychomycosis Market Insights

  • 4.1. Onychomycosis Market - Market Snapshot
  • 4.2. Onychomycosis Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Demand for Topical Therapies is Driving the Market Growth
      • 4.2.1.2. Rising Advanced Technologies is Driving the Market Growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Presence of Alternative Therapies
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Onychomycosis Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Onychomycosis Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • 5.3. Distal Subungual Onychomycosis
    • 5.3.1. Global Onychomycosis Market, by Distal Subungual Onychomycosis, by Region, 2019-2032 (USD Million)
  • 5.4. Proximal Subungual Onychomycosis
    • 5.4.1. Global Onychomycosis Market, by Proximal Subungual Onychomycosis, by Region, 2019-2032 (USD Million)
    • 5.4.2. White Superficial Onychomycosis
      • 5.4.2.1. Global Onychomycosis Market, by White Superficial Onychomycosis, by Region, 2019-2032 (USD Million)
    • 5.4.3. Others
      • 5.4.3.1. Global Onychomycosis Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Onychomycosis Market, by Treatment

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • 6.3. Topical
    • 6.3.1. Global Onychomycosis Market, by Topical, by Region, 2019-2032 (USD Million)
  • 6.4. Oral
    • 6.4.1. Global Onychomycosis Market, by Oral, by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Onychomycosis Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Onychomycosis Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Onychomycosis Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Onychomycosis Market - North America
    • 7.3.1. North America: Onychomycosis Market, by Type, 2019-2032 (USD Million)
    • 7.3.2. North America: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.3.3. Onychomycosis Market - U.S.
      • 7.3.3.1. U.S.: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.3.4. Onychomycosis Market - Canada
      • 7.3.4.1. Canada: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • 7.4. Onychomycosis Market - Europe
    • 7.4.1. Europe: Onychomycosis Market, by Type, 2019-2032 (USD Million)
    • 7.4.2. Europe: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.4.3. Onychomycosis Market - UK
      • 7.4.3.1. UK: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.4.4. Onychomycosis Market - France
      • 7.4.4.1. France: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.4.4.2. France: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.4.5. Onychomycosis Market - Germany
      • 7.4.5.1. Germany: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.4.6. Onychomycosis Market - Italy
      • 7.4.6.1. Italy: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.4.7. Onychomycosis Market - Spain
      • 7.4.7.1. Spain: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.4.8. Onychomycosis Market - Netherlands
      • 7.4.8.1. Netherlands: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.4.9. Onychomycosis Market - Russia
      • 7.4.9.1. Russia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.4.10. Onychomycosis Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.4.10.2. Rest of Europe: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • 7.5. Onychomycosis Market - Asia Pacific
    • 7.5.1. Asia Pacific: Onychomycosis Market, by Type, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.5.3. Onychomycosis Market - China
      • 7.5.3.1. China: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.5.3.2. China: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.5.4. Onychomycosis Market - India
      • 7.5.4.1. India: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.5.4.2. India: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.5.5. Onychomycosis Market - Malaysia
      • 7.5.5.1. Malaysia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.5.6. Onychomycosis Market - Japan
      • 7.5.6.1. Japan: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.5.7. Onychomycosis Market - Indonesia
      • 7.5.7.1. Indonesia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.5.8. Onychomycosis Market - South Korea
      • 7.5.8.1. South Korea: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.5.9. Onychomycosis Market - Australia
      • 7.5.9.1. Australia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.5.9.2. Australia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.5.10. Onychomycosis Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.5.10.2. Rest of Asia Pacific: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • 7.6. Onychomycosis Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Onychomycosis Market, by Type, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.6.3. Onychomycosis Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.6.4. Onychomycosis Market - UAE
      • 7.6.4.1. UAE: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.6.5. Onychomycosis Market - Israel
      • 7.6.5.1. Israel: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.6.6. Onychomycosis Market - South Africa
      • 7.6.6.1. South Africa: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.6.7. Onychomycosis Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.6.7.2. Rest of Middle East & Africa: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • 7.7. Onychomycosis Market - Latin America
    • 7.7.1. Latin America: Onychomycosis Market, by Type, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.7.3. Onychomycosis Market - Mexico
      • 7.7.3.1. Mexico: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.7.4. Onychomycosis Market - Brazil
      • 7.7.4.1. Brazil: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.7.5. Onychomycosis Market - Argentina
      • 7.7.5.1. Argentina: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.7.6. Onychomycosis Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.7.6.2. Rest of Latin America: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Abbott
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Bausch Health Companies Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Cipla Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Merck & Co., Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Moberg Pharma AB
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Novartis AG
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Pfizer Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Sun Pharmaceutical Industries Ltd.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Teva Pharmaceutical Industries Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Zydus Lifesciences
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development

List of Tables:

  • Table 1 Global Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 2 Global Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 3 North America: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 4 North America: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 5 U.S.: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 6 U.S.: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 7 Canada: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 8 Canada: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 9 Europe: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 10 Europe: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 11 UK: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 12 UK: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 13 France: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 14 France: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 15 Germany: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 16 Germany: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 17 Italy: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 18 Italy: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 19 Spain: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 20 Spain: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 21 Netherlands: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 22 Netherlands: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 23 Russia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 24 Russia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 25 Rest of Europe: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 26 Rest of Europe: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 28 Asia Pacific: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 29 China: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 30 China: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 31 India: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 32 India: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 33 Malaysia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 34 Malaysia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 35 Japan: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 36 Japan: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 37 Indonesia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 38 Indonesia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 39 South Korea: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 40 South Korea: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 41 Australia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 42 Australia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 43 Vietnam: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 44 Vietnam: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 45 Rest of Asia Pacific: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 46 Rest of Asia Pacific: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 47 Middle East & Africa: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 48 Middle East & Africa: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 49 Saudi Arabia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 50 Saudi Arabia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 51 UAE: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 52 UAE: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 53 Israel: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 54 Israel: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 55 South Africa: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 56 South Africa: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 57 Rest of Middle East & Africa: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 58 Rest of Middle East & Africa: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 59 Latin America: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 60 Latin America: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 61 Mexico: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 62 Mexico: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 63 Brazil: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 64 Brazil: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 65 Argentina: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 66 Argentina: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 67 Rest of Latin America: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 68 Rest of Latin America: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)

List of Figures:

  • Figure 1. Global Onychomycosis Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Onychomycosis Market, by Type, 2023 & 2032 (USD Million)
  • Figure 8. Market by Treatment
  • Figure 9. Global Onychomycosis Market, by Treatment, 2023 & 2032 (USD Million)
  • Figure 10. Onychomycosis Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 11. Figure 13. Strategic Analysis - Onychomycosis Market